Thereafter, IHC staining of PRMT5 protein in renal cancers from the HPA database and proteomic data from the FUSCC cohort including 232 ccRCC patients confirmed the low-expression of PRMT5 in ccRCC at the protein level. This evidence concerns the gene PRMT5 and renal carcinoma.